Syngene International Share Price

ABOUT Syngene International

• Industry Biotechnology & Drugs
• ISIN INE398R01022
• BSE Code 539268
• NSE Code SYNGENE

Syngene International Limited is an India-based contract research company. The Company is engaged in providing services from early discovery and development to commercial manufacturing for small and large molecules. Its services include drug discovery and development capabilities in medicinal chemistry, biology, in vivo pharmacology, toxicology, custom synthesis, process research and development, current good manufacturing practice (cGMP) manufacturing, formulation and analytical development along with clinical development services. It offers SynVent, a therapeutic discovery and development platform for executing drug discovery projects, which is designed to provide a range of advance programs through target validation, translational interrogation, therapeutic discovery and preclinical development for both large and small molecules, as well as specialty modalities, such as targeted protein degradation. It serves clients ranging from multinational corporations to start-ups.

MANAGEMENT

• Jonathan Hunt Chief Executive Officer, Managing Director, Executive Director, Member of the Executive Committee
• Sibaji Biswas Chief Financial Officer, Member of the Executive Committee
• Mahesh Bhalgat Chief Operating Officer, Member of the Executive Committee
• Kenneth Barr Senior Vice President - Discovery Services, Member of the Executive Committee
• Alex Del Priore Senior Vice President - Manufacturing Services, Member of the Executive Committee
• Jan-Olav Henck Senior Vice President - Development Services, Member of the Executive Committee
• Priyadarshini Mahapatra Compliance Officer, Company Secretary
• Alok Mehrotra Chief Quality Officer, Member of the Executive Committee
• Ashu Tandon Chief Commercial Officer, Member of the Executive Committee